share_log

Semler Scientific to Present at Upcoming Investor Conferences

Semler Scientific to Present at Upcoming Investor Conferences

Semler Science将出席即将举行的投资者大会
PR Newswire ·  2021/08/26 08:06

SANTA CLARA, Calif., Aug. 26, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that Chief Executive Officer Doug Murphy-Chutorian, M.D. and Chief Marketing Officer Dennis Rosenberg will participate in the following investor conferences that are being held virtually in September.

加利福尼亚州圣克拉拉2021年8月26日/美通社/--Semler Science,Inc.(OTCQB:SMLR)是一家提供技术解决方案以提高医疗保健提供者临床有效性和效率的公司,该公司今天宣布,首席执行官Doug Murphy-Chutorian医学博士兼首席营销官丹尼斯·罗森伯格将参加以下投资者会议,这些会议实际上是在9月份举行的。

Colliers 2021 Institutional Investor Conference
Date: September 9, 2021
Format: One-on-one investor meetings

Colliers 2021年机构投资者大会
日期:2021年9月9日形式:一对一投资者会议

H.C. Wainwright & Co. 23rd Annual Global Investment Conference
Date: September 13, 2021
Format: On-demand corporate presentation is available beginning at 7:00 AM ET on September 13, 2021; one-on-one meetings. The webcast of the presentation will be archived for 90 days and may be accessed through the following link: https://journey.ct.events/view/557ff96b-03cc-487d-a12a-85504df11403.

H.C.温赖特公司第23届全球投资年会
日期:2021年9月13日格式:从以下位置开始提供点播公司演示文稿美国东部时间上午7:002021年9月13日;一对一会面。演示文稿的网络直播将存档90天,可通过以下链接访问:Https://journey.ct.events/view/557ff96b-03cc-487d-a12a-85504df11403.

2021 Best Ideas Growth (BIG5) Conference hosted by Lake Street Securities
Date: September 14 & 15, 2021
Format: One-on-one meetings

2021年最佳创意增长(BIG5)大会由Lake Street Securities主办
日期:2021年9月14日和15日形式:一对一会议

About Semler Scientific, Inc.:
Semler Scientific, Inc. is a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Semler Scientific's mission is to develop, manufacture and market innovative products and services that assist its customers in evaluating and treating chronic diseases. Semler Scientific commercially launched its first patented and U.S. Food and Drug Administration, or FDA, cleared product in 2011, and received FDA 510(k) clearance for QuantaFlo®, the next generation version of this product, in 2015. QuantaFlo® is a rapid point-of-care test that measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease. QuantaFlo® is used by Semler Scientific's customers to more comprehensively evaluate their patients for risk of heart attacks and strokes. Semler Scientific believes it is positioned to provide valuable information to its insurance company and physician customers, which in turn permits them to better guide patient care. Additional information about Semler Scientific can be found at semlerscientific.com.

关于塞姆勒科学公司:
Semler Science,Inc.是一家提供技术解决方案的公司,旨在提高医疗保健提供者的临床效果和效率。赛姆勒科学公司的使命是开发、制造和销售创新的产品和服务,帮助其客户评估和治疗慢性病。赛姆勒科学公司于2011年在商业上推出了其首个获得专利的美国食品和药物管理局(FDA)批准的产品,并获得了FDA对QuantaFlo的510(K)批准®,这款产品的下一代版本,在2015年。量子流®是一种快速的护理点测试,测量四肢的动脉血流,以帮助诊断外周动脉疾病。量子流®Semler Science的客户使用该软件来更全面地评估他们的患者心脏病发作和中风的风险。Semler Science相信,它的定位是向其保险公司和医生客户提供有价值的信息,这反过来又允许他们更好地指导患者护理。欲了解有关Semler Science公司的更多信息,请访问SemlerScience fic.com。

INVESTOR CONTACT:
Susan A. Noonan
S.A. Noonan Communications
[email protected]
212 966 3650

投资者联系方式:
苏珊·努南(Susan A.Noonan)美国努南通信公司(S.A.Noonan Communications)[受电子邮件保护]212 966 3650

SOURCE Semler Scientific, Inc.

来源:塞姆勒科学公司

Related Links

相关链接

http://semlerscientific.com

Http://semlerscientific.com

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发